Showing results (511-520 of 528) with videos related to
Sort By:
Pageof 53
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 4, 2012
Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genesBrooke L Fridley, Gregory D Jenkins, Ya-Yu Tsai, et al.Journal of Neuro-Oncology|January 8, 2014
NDRG1 prognosticates the natural course of disease in WHO grade II gliomaJ Blaes, M Weiler, F Sahm, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Inherited determinants of ovarian cancer survivalEllen L Goode, Matthew J Maurer, Thomas A Sellers, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2017
Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular SubtypesStefan Kommoss, Boris Winterhoff, Ann L Oberg, et al.Human Molecular Genetics|April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelMine S Cicek, Devin C Koestler, Brooke L Fridley, et al.Plos One|January 30, 2010
Risk of ovarian cancer and inherited variants in relapse-associated genesAbraham Peedicayil, Robert A Vierkant, Lynn C Hartmann, et al.Bone Marrow Transplantation|August 4, 2009
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinomaM R Litzow, P P Peethambaram, S L Safgren, et al.Journal of Research of the National Institute of Standards and Technology|July 23, 2016
A Critical Evaluation of Interlaboratory Data on Total, Elemental, and Isotopic Carbon in the Carbonaceous Particle Reference Material, NIST SRM 1649aL A Currie, B A Benner, J D Kessler, et al.Nucleic Acids Research|April 29, 2015
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancerJeremy Chien, Hugues Sicotte, Jian-Bing Fan, et al.The Breast Journal|January 15, 2009
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.Pageof 53